Evidence map›Paper›PMID 34367342›Full record

ArticleTherapeutic advances in medical oncology2021

Molecular profiling of soft-tissue sarcomas with FoundationOne

Susanne Scheipl, Iva Brcic, Tina Moser, Stefan Fischerauer, Jakob Riedl, Marko Bergovec, Maria Smolle, Florian Posch, Armin Gerger, Martin Pichler and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in medical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Susanne ScheiplDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-6675-7052
Iva BrcicDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Tina MoserInstitute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Stefan FischerauerDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Jakob RiedlDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Marko BergovecDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Maria SmolleDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Florian PoschDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Armin GergerDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Martin PichlerDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Herbert StoegerDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Andreas LeithnerDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Ellen HeitzerInstitute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Bernadette Liegl-AtzwangerDiagnostic and Research Institute of Pathology, Diagnostic and Research Centre for Molecular BioMedicine, Medical University of Graz, Neue Stiftingtalstraße 10, Graz 8010 Austria.
Joanna SzkanderaDivision of Clinical Oncology, Medical University of Graz, Graz, Austria.
Medical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMolecular diagnosis has become an established tool in the characterisation of adult soft-tissue sarcomas (STS). FoundationOne

methodsWe evaluated FoundationOne

resultsAlthough FoundationOne

conclusionsIn summary, FoundationOne

Indexed as

complex karyotypeFoundationOne® Hemenext-generation sequencingsoft-tissue sarcomatargeted therapytranslocation-associated sarcoma

Identifiers

PMID34367342
PMCPMC8317253
OpenAlexW3183617639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.